You're using an older version of Internet Explorer that is no longer supported. Please update your browser.

AbCellera

About

AbCellera is a technology company with an antibody discovery platform that searches, decodes, and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. AbCellera’s technology, which combines high-throughput microfluidics, hyper-scale data science, machine learning, bioinformatics, and genomics, identifies new drug candidates and aims to reduce the time it takes to bring treatments to the clinic. AbCellera's partners include leading biotechnology companies, global health organizations, and many of the top 10 biopharmaceutical companies.